NRIX
Nurix Therapeutics Inc
NASDAQ: NRIX · HEALTHCARE · BIOTECHNOLOGY
$16.70
+0.54% today
Updated 2026-04-30
Market cap
$1.72B
P/E ratio
—
P/S ratio
23.93x
EPS (TTM)
$-3.17
Dividend yield
—
52W range
$8 – $23
Volume
1.1M
Nurix Therapeutics Inc (NRIX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-1,479.00%
ROE
-61.40%
ROA
-31.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $37.45M | $-9.43M | -8.18% | -26.01% | -25.18% |
| 2019 | $31.11M | $-21.70M | -44.71% | -71.46% | -69.74% |
| 2020 | $17.82M | $-43.24M | 100.00% | -364.66% | -242.66% |
| 2021 | $29.75M | $-117.19M | 100.00% | -396.26% | -393.93% |
| 2022 | $38.63M | $-166.04M | 100.00% | -476.01% | -429.87% |
| 2023 | $76.99M | $-143.95M | -145.69% | -201.41% | -186.98% |
| 2024 | $54.55M | $-193.57M | -306.30% | -390.52% | -354.85% |
| 2025 | $83.98M | $-264.46M | 77.55% | -340.16% | -314.90% |